Target Healthcare REIT (LON:THRL) Reaches New 52-Week High at $92.40

Target Healthcare REIT (LON:THRL)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 92.40 ($1.23) and last traded at GBX 90.40 ($1.21), with a volume of 780771 shares traded. The stock had previously closed at GBX 90.90 ($1.21).

Target Healthcare REIT Price Performance

The stock’s 50 day simple moving average is GBX 83.50 and its 200-day simple moving average is GBX 81.10. The company has a debt-to-equity ratio of 34.92, a current ratio of 1.62 and a quick ratio of 1.52. The company has a market capitalization of £560.70 million, a PE ratio of 754.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.44.

Target Healthcare REIT Announces Dividend

The company also recently announced a dividend, which was paid on Friday, August 30th. Investors of record on Thursday, August 15th were paid a dividend of GBX 1.43 ($0.02) per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a dividend yield of 1.84%. Target Healthcare REIT’s payout ratio is 5,000.00%.

About Target Healthcare REIT

UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes. The Group's portfolio at 31 December 2023 comprised 98 assets let to 32 tenants with a total value of £911.1 million.